• Pronase E Protease Mixture: Precision Protein Sample Prepara

  2026-07-06

  Pronase E empowers molecular biology labs with unmatched proteolytic breadth, driving reproducible protein digestion and peptide mapping for advanced research. Discover workflow upgrades, troubleshooting strategies, and practical assay improvements that set Pronase E apart for proteomics and ferroptosis studies.

• HyperScript™ Reverse Transcriptase for Robust cDNA Synthesis

  2026-07-05

  HyperScript™ Reverse Transcriptase sets a new benchmark for high-fidelity cDNA synthesis from challenging RNA templates—thanks to its thermal stability and low RNase H activity. Its unique attributes empower sensitive detection of low-abundance transcripts and structured RNAs, accelerating workflows in molecular biology and viral quantification.

• Neticonazole Hydrochloride in Antifungal and Cancer Research

  2026-07-04

  Neticonazole Hydrochloride stands out as a dual-action imidazole antifungal, uniquely bridging effective cutaneous candidiasis treatment with advanced colorectal cancer research applications. Its robust solubility and validated performance in both fungal and tumor models provide experimental versatility and translational relevance.

• Dissecting ACE2 Peptidase Activity: Substrate Preferences an

  2026-07-03

  This study by Saulnier et al. delivers a detailed mechanistic analysis of ACE2 peptidase activity, revealing how substrate structure, particularly the C-terminal Phe, governs ACE2's efficiency in generating Angiotensin (1-7). The findings refine our molecular understanding of the renin–angiotensin system and offer precise guidance for research into anti-fibrotic and anti-inflammatory signaling.

• EZ Cap™ EPO mRNA (ψUTP): Optimized mRNA for Erythropoiesis &

  2026-07-03

  EZ Cap™ EPO mRNA (ψUTP) is a stabilized, in vitro transcribed human erythropoietin mRNA with enhanced translation and reduced immunogenicity. It enables efficient protein expression for erythropoiesis and neuroprotection research, with proven stability and targeted delivery benchmarks.

• MDM1 Overexpression Enhances Apoptosis and Therapy Response

  2026-07-02

  This study identifies MDM1 as a regulator of chemoradiotherapy sensitivity in colorectal cancer by promoting p53-mediated apoptosis. The findings position MDM1 as a predictive biomarker for therapy outcome and highlight the value of apoptosis-inducing strategies in CRC treatment.

• DiscoveryProbe Protease Inhibitor Library: Mechanistic Insig

  2026-07-02

  Explore the DiscoveryProbe Protease Inhibitor Library's advanced role in protease inhibition research, with a deep dive into mechanistic innovations and practical assay optimization. This article uniquely integrates recent molecular insights to guide high-throughput and high-content screening decisions.

• AI-Derived Prognostic Signature Refines HCC Risk Stratificat

  2026-07-01

  This large-scale, multi-center study introduces a consensus artificial intelligence-derived prognostic signature (CAIPS) that outperforms traditional methods in predicting outcomes for hepatocellular carcinoma (HCC) patients. Integrating diverse machine learning algorithms, CAIPS enables robust risk stratification and guides targeted therapeutic strategies, advancing the precision oncology landscape.

• Lambda Protein Phosphatase: Precision in Phosphorylation Val

  2026-07-01

  Lambda Protein Phosphatase (RNase-free) from APExBIO sets a new standard for phosphorylation analysis, enabling high-confidence validation of phospho-specific antibodies and functional studies of regulatory protein modifications. Its robust dual-specificity and RNase-free purity streamline even the most challenging circadian and signaling workflows.

• Birinapant (TL32711): Enhancing Apoptosis Workflows in Cance

  2026-06-30

  Birinapant (TL32711) is a premier SMAC mimetic IAP antagonist, enabling precise induction of apoptosis and TRAIL sensitization in resistant cancer models. This article translates the latest reference study findings and hands-on protocols into actionable strategies for maximizing Birinapant's impact in apoptosis research.

• hiPSC-Derived Intestinal Organoids Advance Pharmacokinetics

  2026-06-30

  The referenced study establishes a direct 3D protocol for generating human induced pluripotent stem cell-derived intestinal organoids, offering a more physiologically relevant platform for pharmacokinetic studies. This innovation addresses longstanding limitations of traditional models and enables robust assessment of drug absorption and metabolism, with direct implications for benchmarking compounds such as Phenacetin.

• Ganetespib (STA-9090): Optimizing Hsp90 Inhibition in Cancer

  2026-06-29

  Ganetespib (STA-9090) delivers robust, selective Hsp90 inhibition, driving rapid degradation of oncogenic client proteins for advanced cancer research. This guide decodes practical workflows, troubleshooting tactics, and the latest cross-domain insights to maximize reproducibility and assay sensitivity using APExBIO’s trusted compound.

• UTP Solution: Precision Uridine-5'-triphosphate for RNA Assa

  2026-06-29

  UTP Solution (100 mM) empowers high-fidelity RNA synthesis and advanced gene expression studies with unmatched purity and workflow flexibility. Its DNase/RNase-free formulation from APExBIO ensures robust in vitro transcription and metabolic research, supporting nuanced experimental designs and rapid troubleshooting.

• Phillygenin Inhibits Inflammation and Apoptosis in Diabetic

  2026-06-28

  This study demonstrates that phillygenin, a natural lignan, significantly ameliorates diabetic nephropathy by targeting the TLR4/MyD88/NF-κB and PI3K/AKT/GSK3β pathways to suppress inflammation and apoptosis. These mechanistic insights highlight phillygenin's potential as a novel therapeutic agent for diabetic kidney disease.

• Cytoskeleton Dependence in Mechanical Stress-Induced Autopha

  2026-06-27

  This study provides direct evidence that the cytoskeleton, especially microfilaments, is essential for mechanical stress-induced autophagy in human cells. The findings clarify how cytoskeletal components transduce mechanical signals to autophagic pathways, with important implications for research on cellular adaptation, mechanotransduction, and redox modulation.

472 records 7/32 page Previous Next First page 上5页 678910 下5页 Last page